Skip to content
10-Q

Quarterly Report

TREVI THERAPEUTICS, INC. TRVI

0000950170-25-105066

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 121.78M sh
Shares Diluted Q2 2025 · Jun 30, 2025 130.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 124.02M sh
Shares Diluted Q2 2025 · Jun 30, 2024 101.04M sh
Shares Diluted Q2 2025 · Jun 30, 2024 100.28M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $28K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$23.58M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$19.15M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $117.06M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $34.1M
Stockholders Equity Q2 2025 · Jun 30, 2025 $198.49M
Stockholders Equity Q2 2025 · Mar 31, 2025 $99.46M
Stockholders Equity Q2 2025 · Dec 31, 2024 $99.64M
Stockholders Equity Q2 2025 · Jun 30, 2024 $66.17M
Stockholders Equity Q2 2025 · Mar 31, 2024 $72.33M
Stockholders Equity Q2 2025 · Dec 31, 2023 $82.55M
Current Liabilities Q2 2025 · Jun 30, 2025 $9.24M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.51M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.85M
Total Liabilities Q2 2025 · Dec 31, 2024 $11.26M
Current Assets Q2 2025 · Jun 30, 2025 $207.23M
Current Assets Q2 2025 · Dec 31, 2024 $109.43M
Total Assets Q2 2025 · Jun 30, 2025 $208.34M
Total Assets Q2 2025 · Dec 31, 2024 $110.9M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.09
Eps Basic Q2 2025 · Jun 30, 2025 −$0.18
Eps Basic Q2 2025 · Jun 30, 2024 −$0.12
Eps Basic Q2 2025 · Jun 30, 2024 −$0.23
Sga Expense Q2 2025 · Jun 30, 2025 $4.33M
Sga Expense Q2 2025 · Jun 30, 2025 $7.99M
Sga Expense Q2 2025 · Jun 30, 2024 $3.27M
Sga Expense Q2 2025 · Jun 30, 2024 $6.37M
Rd Expense Q2 2025 · Jun 30, 2025 $9.39M
Rd Expense Q2 2025 · Jun 30, 2025 $17.2M
Rd Expense Q2 2025 · Jun 30, 2024 $10.02M
Rd Expense Q2 2025 · Jun 30, 2024 $18.83M
Net Income Q2 2025 · Jun 30, 2025 −$12.3M
Net Income Q2 2025 · Jun 30, 2025 −$22.64M
Net Income Q2 2025 · Jun 30, 2024 −$12.35M
Net Income Q2 2025 · Jun 30, 2024 −$23.25M
Operating Income Q2 2025 · Jun 30, 2025 −$13.72M
Operating Income Q2 2025 · Jun 30, 2025 −$25.19M
Operating Income Q2 2025 · Jun 30, 2024 −$13.29M
Operating Income Q2 2025 · Jun 30, 2024 −$25.2M